Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage

In 1-5 % of patients during childbearing years recurrent miscarriages (RM) occur. There are established risk factors like anatomical, endocrine and hemostatic disorders as well as immunological changes in the maternal immune system. Nevertheless, further elucidation of the pathogenesis remains a mat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Santjohanser, Claudia (VerfasserIn) , Knieper, Catherine Linn (VerfasserIn) , Franz, Cordula (VerfasserIn) , Hirv, Kaino (VerfasserIn) , Meri, Osama (VerfasserIn) , Schleyer, Manfred (VerfasserIn) , Würfel, Wolfgang (VerfasserIn) , Toth, Bettina (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 24 January 2013
In: Archivum immunologiae et therapiae experimentalis
Year: 2013, Jahrgang: 61, Heft: 2, Pages: 159-164
ISSN:1661-4917
DOI:10.1007/s00005-012-0212-z
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00005-012-0212-z
Volltext
Verfasserangaben:Claudia Santjohanser, Catherine Knieper, Cordula Franz, Kaino Hirv, Osama Meri, Manfred Schleyer, Wolfgang Würfel, Bettina Toth

MARC

LEADER 00000caa a2200000 c 4500
001 1787775437
003 DE-627
005 20240415193321.0
007 cr uuu---uuuuu
008 220131s2013 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00005-012-0212-z  |2 doi 
035 |a (DE-627)1787775437 
035 |a (DE-599)KXP1787775437 
035 |a (OCoLC)1341439472 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Santjohanser, Claudia  |e VerfasserIn  |0 (DE-588)1234107007  |0 (DE-627)1758979194  |4 aut 
245 1 0 |a Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage  |c Claudia Santjohanser, Catherine Knieper, Cordula Franz, Kaino Hirv, Osama Meri, Manfred Schleyer, Wolfgang Würfel, Bettina Toth 
264 1 |c 24 January 2013 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 31.01.2022 
520 |a In 1-5 % of patients during childbearing years recurrent miscarriages (RM) occur. There are established risk factors like anatomical, endocrine and hemostatic disorders as well as immunological changes in the maternal immune system. Nevertheless, further elucidation of the pathogenesis remains a matter of debate. In addition, there are no standardized immunological treatment strategies. Recent studies indicate possible effects of tumor necrosis factor α blocker and granulocyte-colony stimulating factor (G-CSF) concerning live birth rate (LBR) in RM patients. Therefore, we performed a retrospective cohort study in patients undergoing assisted reproductive treatment (ART) with known RM analysing the possible benefits of G-CSF application. From January 2002 to December 2010, 127 patients (199 cylces) with RM (at least 2 early miscarriages) 49 (72 cycles) receiving G-CSF and 78 (127 cycles) controls receiving either no medication (subgroup 1) or Cortisone, intravenous immunoglobulins or low molecular weight heparin (subgroup 2) undergoing ART for in vitro fertilisation/intracytoplasmic sperm injection were analysed. G-CSF was administered weekly once (34 Mill) in 11 patients, 38 patients received 2 × 13 Mill G-CSF per week until the 12th week of gestation. Statistical analysis was performed with SPSS for Windows (19.0), p < 0.05 significant. The mean age of the study population was 37.3 ± 4.4 years (mean ± standard deviation) and differed not significantly between patients and subgroups. However, the number of early miscarriages was significantly higher in the G-CSF group as compared to the subgroups (G-CSF 2.67 ± 1.27, subgroup 1 0.85 ± 0.91, subgroup 2 0.64 ± 0.74) and RM patients receiving G-CSF had significantly more often a late embryo transfer (day 5) (G-CSF 36.7 %, subgroup 1 12.1 %, subgroup 2 8.9 %). The LBR of patients and the subgroups differed significantly (G-CSF 32 %, subgroup 1 13 %, subgroup 2 14 %). Side effects were present in less than 10 % of patients, consisting of irritation at the injection side, slight leukocytosis, rise of the temperature (<38 °C), mild bone pain and hyperemesis gravidarum. None of the newborn showed any kind of malformations. According to our data, G-CSF seems to be a safe and promising immunological treatment option for RM patients. However, with regard to the retrospective setting and the possible bias of a higher rate of late embryo transfers in the G-CSF group additional studies are needed to further strengthen our results. 
700 1 |a Knieper, Catherine Linn  |d 1987-  |e VerfasserIn  |0 (DE-588)1070542385  |0 (DE-627)823999688  |0 (DE-576)430205864  |4 aut 
700 1 |a Franz, Cordula  |d 1987-  |e VerfasserIn  |0 (DE-588)1063812887  |0 (DE-627)812618106  |0 (DE-576)423241850  |4 aut 
700 1 |a Hirv, Kaino  |e VerfasserIn  |4 aut 
700 1 |a Meri, Osama  |e VerfasserIn  |4 aut 
700 1 |a Schleyer, Manfred  |e VerfasserIn  |4 aut 
700 1 |a Würfel, Wolfgang  |e VerfasserIn  |4 aut 
700 1 |a Toth, Bettina  |d 1971-  |e VerfasserIn  |0 (DE-588)115537457  |0 (DE-627)691388032  |0 (DE-576)177266228  |4 aut 
773 0 8 |i Enthalten in  |t Archivum immunologiae et therapiae experimentalis  |d Warsaw, Poland : Sciendo, 1994  |g 61(2013), 2, Seite 159-164  |h Online-Ressource  |w (DE-627)389872318  |w (DE-600)2149971-8  |w (DE-576)281253188  |x 1661-4917  |7 nnas  |a Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage 
773 1 8 |g volume:61  |g year:2013  |g number:2  |g pages:159-164  |g extent:6  |a Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage 
856 4 0 |u https://doi.org/10.1007/s00005-012-0212-z  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220131 
993 |a Article 
994 |a 2013 
998 |g 115537457  |a Toth, Bettina  |m 115537457:Toth, Bettina  |d 910000  |d 910400  |e 910000PT115537457  |e 910400PT115537457  |k 0/910000/  |k 1/910000/910400/  |p 8  |y j 
998 |g 1063812887  |a Franz, Cordula  |m 1063812887:Franz, Cordula  |d 50000  |e 50000PF1063812887  |k 0/50000/ 
998 |g 1070542385  |a Knieper, Catherine Linn  |m 1070542385:Knieper, Catherine Linn  |d 50000  |e 50000PK1070542385  |k 0/50000/  |p 2 
999 |a KXP-PPN1787775437  |e 4048129783 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Santjohanser, Claudia","given":"Claudia","family":"Santjohanser"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Knieper, Catherine Linn","given":"Catherine Linn","family":"Knieper"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Franz, Cordula","given":"Cordula","family":"Franz"},{"family":"Hirv","given":"Kaino","roleDisplay":"VerfasserIn","display":"Hirv, Kaino","role":"aut"},{"given":"Osama","family":"Meri","role":"aut","display":"Meri, Osama","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Schleyer, Manfred","roleDisplay":"VerfasserIn","given":"Manfred","family":"Schleyer"},{"given":"Wolfgang","family":"Würfel","role":"aut","roleDisplay":"VerfasserIn","display":"Würfel, Wolfgang"},{"roleDisplay":"VerfasserIn","display":"Toth, Bettina","role":"aut","family":"Toth","given":"Bettina"}],"title":[{"title_sort":"Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage","title":"Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 31.01.2022"],"recId":"1787775437","language":["eng"],"name":{"displayForm":["Claudia Santjohanser, Catherine Knieper, Cordula Franz, Kaino Hirv, Osama Meri, Manfred Schleyer, Wolfgang Würfel, Bettina Toth"]},"origin":[{"dateIssuedDisp":"24 January 2013","dateIssuedKey":"2013"}],"id":{"eki":["1787775437"],"doi":["10.1007/s00005-012-0212-z"]},"physDesc":[{"extent":"6 S."}],"relHost":[{"title":[{"title_sort":"Archivum immunologiae et therapiae experimentalis","subtitle":"AITE","title":"Archivum immunologiae et therapiae experimentalis"}],"pubHistory":["Nachgewiesen 42.1994 -"],"part":{"year":"2013","pages":"159-164","issue":"2","volume":"61","text":"61(2013), 2, Seite 159-164","extent":"6"},"titleAlt":[{"title":"AITE"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriageArchivum immunologiae et therapiae experimentalis","note":["Gesehen am 27.03.24","Frühere Jg. online nicht mehr verfügbar"],"language":["eng"],"corporate":[{"display":"Instytut Immunologii i Terapii Doświadczalnej Imienia Ludwika Hirszfelda","roleDisplay":"Herausgebendes Organ","role":"isb"}],"recId":"389872318","origin":[{"publisherPlace":"Warsaw, Poland ; Boston, MA ; Wrocław ; Basel ; Basel ; [Cham (ZG)]","dateIssuedKey":"2024","publisher":"Sciendo ; IITD PAN ; Birkhäuser ; Springer ; [Springer International Publishing AG]","dateIssuedDisp":"2024-"}],"id":{"zdb":["2149971-8"],"eki":["389872318"],"issn":["1661-4917"]},"name":{"displayForm":["Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław"]},"physDesc":[{"extent":"Online-Ressource"}]}]} 
SRT |a SANTJOHANSGRANULOCYT2420